On the other hand, ascorbate treatment was also associated with increase in IGFBP7, a known tumour suppressor [63,64,65] that is thought to compete with insulin-like growth factor binding [66] or cause oncogene-induced senescence [67], and has been recently shown to be produced by macrophages [68]. Here, IGFBP7 is linked to neoplasm.